Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

NCT04699721

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Active, not recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

Emory University Atlanta, Georgia, United States

Karmanos Cancer Institute Detroit, Michigan, United States

R.J.Zuckerberg Cancer Center Lake Success, New York, United States

View all 13 locations

View Trial Details

Active, not recruiting

Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations

NCT04687241

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Jilin Province Cancer Hospital Changchun, Jilin, China

View Trial Details

Active, not recruiting

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

NCT04127110

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

CHU-UCL Namur - CHU Mont Godinne - UCL Namur Yvoir, Belgium

View all 26 locations

View Trial Details

Active, not recruiting

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

NCT05566041

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Small Cell Lung, +8 more
Locations: H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States

The University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Active, not recruiting

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

NCT03769103

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +15 more
Locations: BC Cancer, Vancouver Centre Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Active, not recruiting

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

NCT05620134

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +86 more
Locations: Institut Jules Bordet Brussels, Belgium

UZA Edegem, Belgium

UZ Ghent Ghent, Belgium

CHU UCL Namur - site Godinne Yvoir, Belgium

View Trial Details

Active, not recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations: NGM Clinical Study Site Gilbert, Arizona, United States

NGM Clinical Study Site Los Angeles, California, United States

NGM Clinical Study Site Sarasota, Florida, United States

NGM Clinical Study Site Tampa, Florida, United States

View Trial Details

Active, not recruiting

Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences

NCT06616909

Conditions: Advanced Care Planning (ACP), Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Active, not recruiting

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

NCT06569420

Conditions: ALK-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Shanghai Pulmonary Hospital Shanghai, China

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions